DaVita Inc. Common Stock (DVA): Corp. News News

DVA – DaVita to sell its DaVita Medical Group unit to UnitedHealth’s Optum for approximately $4.9 bln in cash.

Key Facts Surrounding This News Item

  • DVA had a POWR Rating of B (Buy) coming into today.
  • DVA was 3.30% above its 10-Day Moving Average coming into today.
  • DVA was 6.65% above its 20-Day Moving Average coming into today.
  • DVA was 4.71% above its 50-Day Moving Average coming into today.
  • DVA was 3.39% above its 100-Day Moving Average coming into today.
  • DVA was -2.89% below its 200-Day Moving Average coming into today.
  • DVA had returned -5.09% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About DaVita Inc. Common Stock (DVA)

DaVita Healthcare Partners delivers dialysis services to patients with chronic kidney failure and end stage renal disease. The company was founded in 1994 and is based in Denver, Colorado. View our full DVA ticker page with ratings, news, and more.

Try StockNews.com Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

DVA at a Glance

DVA Current POWR Rating™
Overall POWR Rating™
DVA Current Price $72.18 0.18%
More DVA Ratings, Data, and News

DVA Price Reaction

The day of this event (Dec. 6, 2017)
DVA Closing Price$69.20 13.57%
DVA Volume9,753,800
501.84% from avg
Leading up to this event
DVA 1-mo return2.56%
After this event
DVA 1-day return9.25%
DVA 3-day return12.34%
DVA 5-day return14.54%

DVA Price Chart

More DaVita Inc. Common Stock (DVA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All DVA News
Page generated in 1.6262 seconds.